Overview

Study of the Gut Hormone Analogue Y14 in Adult Subjects

Status:
Completed
Trial end date:
2018-12-24
Target enrollment:
Participant gender:
Summary
A randomised, placebo controlled Phase I study to investigate investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of Y14 in adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Imperial College London
Collaborators:
Covance
Medical Research Council